Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02725788 · ClinicalTrials.gov registry record · NA
Trial Comparing Peripheral I.V. Catheter Complication Rates of Two Different Catheter Dressings
A NA study, sponsored by Solventum US.
- Terminated
- Registry status
- NA
- Development phase
- 247
- Enrollment target
NCT02725788: Clinical Trial NA study, sponsored by Solventum US.
NCT02725788 is a NA study that was terminated before completion, run by Solventum US. The registered enrollment target is 247 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02725788, a NA study, was terminated before completion, sponsored by Solventum US.
- TERMINATED
- Registry status
- NA
- Development phase
- 247 participants
- Enrollment target
Study Summary
A multi-center randomized control trial comparing the dressing wear times of two different transparent film dressings when used to secure peripheral intravenous catheters of hospitalized adult patients.
Primary Outcome
Dressing wear time is the time from dressing application to removal, i.e. catheter no longer needed or catheter-related complication occurs (remove dressing and catheter) OR excessive dressing lift requiring dressing replacement.
Interventions
- DEVICE New PIV Dressing
- DEVICE Standard PIV Dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-05 |
| Phase | NA |
Why NCT02725788 stopped before completion
NCT02725788 is an interventional study that assigns participants to a tested intervention. The registered 247 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which New PIV Dressing is the first listed.
NCT02725788 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02725788 about?
NCT02725788 is a clinical study titled "Trial Comparing Peripheral I.V. Catheter Complication Rates of Two Different Catheter Dressings". A multi-center randomized control trial comparing the dressing wear times of two different transparent film dressings when used to secure peripheral intravenous catheters of hospitalized adult patients.
What is the current status of trial NCT02725788?
This trial is currently terminated. It is a NA study. The enrollment target is 247 participants. The study started on 2014-09. Estimated completion is 2015-05.
What interventions are being tested in trial NCT02725788?
The interventions under investigation include: New PIV Dressing (DEVICE), Standard PIV Dressing (DEVICE).
Who is sponsoring clinical trial NCT02725788?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02725788's enrollment target sits among peer trials
247 436th of 2000 higher than 1,565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04269902 · 247 participants · Phase 3
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
- NCT04989803 · 247 participants · Phase 1
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
- NCT05521399 · 247 participants
Heart Transplantation - Renewal
- NCT05556824 · 247 participants · Phase 2
Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia